Unclear prospects continue to dampen Evotec s share price on Wednesday after the latest figures. The pharmaceutical drug researcher and developer recorded a weaker start to the year, but above all the.
German biotechnology company Evotec SE announced a deal on Wednesday that expands its partnership with Advanced BioScience Laboratories (ABL) to advance manufacturing processes for HIV neutralizing antibodies. The deal involved its Seattle unit Just-Evotec Biologics, it said. The financial details of the agreement were not yet disclosed. Under the terms, Just-Evotec Biologics will develop a third broadly neutralizing HIV-1 antibody (bNAb) and perform large-scale current good manufacturing practi